Tango Therapeutics (TNGX) Other Non-Current Assets (2020 - 2026)

Tango Therapeutics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 17.73% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 17.73% YoY), while the FY2025 annual figure was $2.1 million, up 53375.0% from the prior year.
• Other Non-Current Assets was $2.1 million for Q1 2026 at Tango Therapeutics, roughly flat from $2.1 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $4.0 million in Q1 2022 to a low of $4000.0 in Q4 2024.
• Historically, Other Non-Current Assets has averaged $2.7 million across 5 years, with a median of $2.6 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets sank 99.88% in 2024, then soared 53375.0% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $4.0 million in 2022, then retreated by 15.0% to $3.4 million in 2023, then tumbled by 99.88% to $4000.0 in 2024, then jumped by 53375.0% to $2.1 million in 2025, then changed by 0.0% to $2.1 million in 2026.
• The last three Other Non-Current Assets figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $290000.0 (Q3 2025), per Business Quant data.